JAMA. 1995 May 10;273(18):1429-35. doi: 10.1001/jama.1995.03520420045036.
To assess the efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol to decrease low-density lipoprotein cholesterol (LDL-C) levels in children.
Six-center randomized controlled clinical trial.
Prepubertal boys (n = 362) and girls (n = 301) aged 8 to 10 years with LDL-C levels greater than or equal to the 80th and less than the 98th percentiles for age and sex were randomized into an intervention group (n = 334) and a usual care group (n = 329).
Behavioral intervention to promote adherence to a diet providing 28% of energy from total fat, less than 8% from saturated fat, up to 9% from polyunsaturated fat, and less than 75 mg/4200 kJ (1000 kcal) per day of cholesterol (not to exceed 150 mg/d).
The primary efficacy measure was the mean LDL-C level at 3 years. Primary safety measures were mean height and serum ferritin levels at 3 years. Secondary efficacy outcomes were mean LDL-C levels at 1 year and mean total cholesterol levels at 1 and 3 years. Secondary safety outcomes included red blood cell folate values; serum zinc, retinol, and albumin levels; serum high-density lipoprotein cholesterol (HDL-C) values, LDL-C:HDL-C ratio, and total triglyceride levels; sexual maturation; and psychosocial health.
At 3 years, dietary total fat, saturated fat, and cholesterol levels decreased significantly in the intervention group compared with the usual care group (all P < .001). Levels of LDL-C decreased in the intervention and usual care groups by 0.40 mmol/L (15.4 mg/dL) and 0.31 mmol/L (11.9 mg/dL), respectively. Adjusting for baseline level and sex and imputting values for missing data, the mean difference between the groups was -0.08 mmol/L (-3.23 mg/dL) (95% confidence interval [CI], -0.15 to -0.01 mmol/L [-5.6 to -0.5 mg/dL]), which was significant (P = .02). There were no significant differences between the groups in adjusted mean height or serum ferritin levels (P > .05) or other safety outcomes.
The dietary intervention achieved modest lowering of LDL-C levels over 3 years while maintaining adequate growth, iron stores, nutritional adequacy, and psychological well-being during the critical growth period of adolescence.
评估降低饮食中总脂肪、饱和脂肪和胆固醇摄入量以降低儿童低密度脂蛋白胆固醇(LDL-C)水平的疗效和安全性。
六中心随机对照临床试验。
8至10岁的青春期前男孩(n = 362)和女孩(n = 301),其LDL-C水平大于或等于年龄和性别的第80百分位数且小于第98百分位数,被随机分为干预组(n = 334)和常规护理组(n = 329)。
行为干预,以促进坚持一种饮食,该饮食提供的能量中28%来自总脂肪,饱和脂肪占比低于8%,多不饱和脂肪占比高达9%,每天胆固醇摄入量低于75 mg/4200 kJ(1000千卡)(不超过150 mg/天)。
主要疗效指标是3年时的平均LDL-C水平。主要安全性指标是3年时的平均身高和血清铁蛋白水平。次要疗效结局是1年时的平均LDL-C水平以及1年和3年时的平均总胆固醇水平。次要安全性结局包括红细胞叶酸值;血清锌、视黄醇和白蛋白水平;血清高密度脂蛋白胆固醇(HDL-C)值、LDL-C:HDL-C比值和总甘油三酯水平;性成熟;以及心理社会健康状况。
3年时,与常规护理组相比,干预组的饮食中总脂肪、饱和脂肪和胆固醇水平显著降低(均P <.001)。干预组和常规护理组的LDL-C水平分别降低了0.40 mmol/L(15.4 mg/dL)和0.31 mmol/L(11.9 mg/dL)。在对基线水平、性别进行调整并对缺失数据进行插补后,两组之间的平均差异为-0.08 mmol/L(-3.23 mg/dL)(95%置信区间[CI],-0.15至-0.01 mmol/L[-5.6至-0.5 mg/dL]),具有显著性(P =.02)。在调整后的平均身高、血清铁蛋白水平(P >.05)或其他安全性结局方面,两组之间无显著差异。
饮食干预在3年期间适度降低了LDL-C水平,同时在青春期这个关键生长阶段维持了充足的生长、铁储备、营养充足以及心理健康。